A0A2R9ABM9 (A0A2R9ABM9_PANPA) Pan paniscus (Pygmy chimpanzee) (Bonobo)
O-GlcNAcase UniProtKBInterProInteractive Modelling
916 aa; Sequence (Fasta) ;
3 identical sequences: Homo sapiens: O60502; Gorilla gorilla gorilla: G3QK87; Piliocolobus tephrosceles: A0A8C9LSW2
It is possible new templates exist for this target since these models were created.
Available Structures
22 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of Eukaryotic Hydrolase |
Heteromer O60502; | |||||
| Assess | ||||||
| Structural Investigations of the Substrate Specificity of Human O-GlcNAcase |
Heteromer O60502; | |||||
| Assess | ||||||
| Crystal Structure of human O-GlcNAcase in complex with glycopeptide p53 |
Heteromer O60502; P04637; | 2×NAG; | ||||
| Assess | ||||||
| The crystal structure of human O-GlcNAcase in complex with Thiamet-G |
Heteromer O60502; | 2×NHT; | ||||
| Assess | ||||||
| Structural Investigations of the Substrate Specificity of Human O-GlcNAcase |
Heteromer O60502; Q15750; | 2×NAG; | ||||
| Assess | ||||||
| Structural Investigations of the Substrate Specificity of Human O-GlcNAcase |
Heteromer O60502; P19419; | 2×NAG; | ||||
| Assess | ||||||
| Crystal structure of the core catalytic domain of human O-GlcNAcase |
Heteromer O60502; | 2×GOL; | ||||
| Assess | ||||||
| Structural Investigations of the Substrate Specificity of Human O-GlcNAcase |
Heteromer O60502; P02511; | 2×NAG; | ||||
| Assess | ||||||
| Crystal structure of the core catalytic domain of human O-GlcNAcase bound to MK-8719 |
Heteromer O60502; | 2×OQ1; | ||||
| Assess | ||||||
| Structural Investigations of the Substrate Specificity of Human O-GlcNAcase |
Heteromer O60502; P20700; | 2×NAG; | ||||
| Assess | ||||||
| Crystal structure of the core catalytic domain of Human O-GlcNAcase |
Heteromer O60502; | 3×GOL; | ||||
| Assess | ||||||
| Crystal structure of the core catalytic domain of human O-GlcNAcase complexed with Thiamet G |
Heteromer O60502; | 2×8BJ; | ||||
| Assess | ||||||
| Crystal structure of the core catalytic domain of human O-GlcNAcase complexed with PUGNAc |
Heteromer O60502; | 2×OAN; | ||||
| Assess | ||||||
| Cryo-EM structure of human OGT-OGA complex |
Heteromer O15294; O60502; | 1×UDP; 1×NAG; | ||||
| Assess | ||||||
| CpOGA D298N in complex with hOGA-derived O-GlcNAc peptide |
Heteromer O60502; Q0TR53; | 19×CD; 1×NAG; | ||||
| Assess | ||||||
| Crystal structure of surface entropy mutant of human O-GlcNAc hydrolase | homo-2-mer | |||||
| Assess | ||||||
| Structure of human O-GlcNAc hydrolase | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of human O-GlcNAcase in complex with an S-linked CKII peptide | homo-2-mer | 1×CYS; 1×SER; 1×NAG; | ||||
| Assess | ||||||
| Structure of human O-GlcNAc hydrolase with bound transition state analog ThiametG | homo-2-mer | 2×NHT; | ||||
| Assess | ||||||
| Structure of human O-GlcNAc hydrolase with new iminocyclitol type inhibitor | homo-2-mer | 2×XHA; | ||||
| Assess | ||||||
| Structure of human O-GlcNAc hydrolase with PugNAc type inhibitor | homo-2-mer | 2×GDV; | ||||
| Assess | ||||||
| Human O-GlcNAc hydrolase in complex with DNJNAc-thiazolidines | homo-2-mer | 2×1XI; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5m7r.1.A | homo-2-mer | 0.70 | 100.00 | |||
| Assess | ||||||
| 5tke.1.A | homo-2-mer | 0.67 | 98.21 | |||
| Assess | ||||||
| 7yeh.1.C | monomer | 0.63 | 100.00 | |||
| Assess | ||||||